SEC Form 4 · accession 0001209191-16-138546
FATE THERAPEUTICS INC · FATE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J Scott Wolchko
Officer — President and CEO · Director
Period of report
Aug 23, 2016
Accepted (ET)
Aug 24, 2016 · 6:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 23, 2016 | M | 2,570 | $1.37 | A | 142,049 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F1 | $1.37 | Aug 23, 2016 | M | 2,570 | D | — | Jul 23, 2022 | Common Stock | 2,570 | 0 | D |
Explanation of responses
- F1The shares subject to this option became fully vested and exercisable on July 3, 2016.
- F2Not applicable.